Various treatment formats, either in a live-in facility or through regular visits to a clinic, are designed for ongoing support, to help maintain recovery, and to prevent relapse.
What happens when shame becomes chronic or toxic? Individuals with substance use disorders are presenting with unconscious, untreated toxic shame, yet this subject is underacknowledged in addiction treatment and the wider field. When we understand the role of shame in addiction, we see the need for wrap-around care, systemic and depth approaches - and why we need to include children and family members in treatment.
The CSAM-SMCA 2026 Scientific Conference is Canada’s premier education and networking event for addiction medicine practitioners. This annual event brings together researchers, leaders, educators, and clinicians in addiction medicine for three days of learning and networking.
For the first time, the International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA) and the International Consortium of Universities for Drug Demand Reduction (ICUDDR) will co-host a thematic meeting in Africa focused on the future of Screening, Brief Intervention, and Referral to Treatment (SBIRT) across the continent, in collaborat
On behalf of the International Society of Addiction Medicine, the Netherlands Society of Addiction Medicine and NOVA Postgraduate Training Institute for Addiction Medicine, we welcome you to the XXVIII ISAM Congress in Rotterdam, the Netherlands.
This interactive training covers the 2025 updates to the NAADAC Code of Ethics and provides practical tools for ethical decision-making in behavioral health. Using real-world case studies, participants will explore boundary management, dual relationships, ethical self-disclosure, and strategies to prevent burnout and countertransference.
Substance use disorders (SUDs) are common, affecting at least 1 of 3 adult Americans at some point in their lives. One of the many characteristics of SUDs that makes them unique is that the nature of the addictive process is such that denial, minimization, and lack of insight are natural components of the development of the disorder.
The 17th European Opiate Addiction Treatment Association (EUROPAD) conference will be held in Bucharest, Romania on May 29-31, 2026.
Symposia have a central theme around which the EUROPAD2026BUCHAREST scientific committee has identified topics. The structure of the symposium will take the shape of 3 presentations with 30 minutes per presentation. The length of each symposium is 90 minutes.